Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy

Journal:

Cell

Published:

2025-11-19

DOI:

10.1016/j.cell.2025.10.030

Affiliations:

4

Authors:

17

Go to article

Institutions	Authors	Share
Weizmann Institute of Science (WIS), Israel	11.000000 11.000000	0.65
Immunai Inc., United States of America (USA)	5.000000	0.29
Hadassah Medical Center, HUJI, Israel	0.500000	0.03
Immunai - Israel, Israel	0.500000	0.03

Interested in Immunology?